Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
about
The soluble CD40 ligand sCD154 in systemic lupus erythematosusThe CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory moleculesRole of innate immune factors in the adjuvant activity of monophosphoryl lipid A.Fibroblast and T cells conditioned media induce maturation dendritic cell and promote T helper immune responseRecent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells.The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome.Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.Molecular mechanism and function of CD40/CD40L engagement in the immune system.Role of CD80 in stimulating T lymphocyte activation.CD40-associated TRAF 6 signaling is required for disease induction in a retrovirus-induced murine immunodeficiency.CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues.Irradiation up-regulates CD80 expression through induction of tumour necrosis factor-alpha and CD40 ligand expression on B lymphoma cells.Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells.Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate.Chimeric form of tumor necrosis factor-alpha has enhanced surface expression and antitumor activity.Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases.
P2860
Q33858548-0C3E6254-C4AF-4754-BFB2-3F5F6A4FE6E5Q34354116-F642FBBA-3BAB-4883-B352-7D882A0EA4B4Q34933694-0F92F678-7871-470D-8A62-E8925CC60E8FQ35034710-C9839AFB-2D51-4665-A19C-1FF8B209EADFQ36194575-BF2D5C28-4E63-4E1B-9AFB-D1B79E9EE857Q36483852-85A28C33-3D84-4A05-B107-96122EA0356DQ37378914-9D4882CE-EBB5-4B75-A6F1-3DF4479F73A1Q37474929-845D4BE2-3F7A-4DC4-9786-39C5F6645921Q40307918-64D6CA15-09BB-425D-9914-F4B11B4F524CQ40883636-3427C6BB-8E50-491C-9977-8A18D6DACC94Q41404432-2489577B-4203-455C-8E87-ECCDBF1343A8Q44052198-15D746BF-D03C-4B6D-9751-0E061FB7F7AEQ44899128-138F6F14-15B8-47DE-873D-7CB83EEA29A6Q45876624-1283018B-848E-49ED-A527-9DEEE4011174Q46830804-699EC3F4-707B-42AF-97CE-C8A6E7F4F78DQ46894623-33EDAD39-3235-447C-B218-364376B8E4B0Q49188389-276A8135-FBCE-40FE-8EA9-6A93263A78EF
P2860
Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Tumor necrosis factor-alpha fa ...... ion by IL-4, IL-10, and CD40L.
@en
type
label
Tumor necrosis factor-alpha fa ...... ion by IL-4, IL-10, and CD40L.
@en
prefLabel
Tumor necrosis factor-alpha fa ...... ion by IL-4, IL-10, and CD40L.
@en
P356
P1433
P1476
Tumor necrosis factor-alpha fa ...... ion by IL-4, IL-10, and CD40L.
@en
P2093
P304
P356
10.1006/CIMM.1995.1031
P577
1995-04-01T00:00:00Z